Edwards’ JenaValve deal could strengthen market position, remove potential competition, Austrian regulator says
MLex Summary: Edwards Lifesciences’s takeover of JenaValve Technology could strengthen its “already strong” position in the market for valves for treating aortic regurgitation and aortic stenosis, the Austrian competition authority said...To view the full article, register now.
Already a subscriber? Click here to view full article